Inventor · disambiguated record
Dmitry Samarsky
Also filed as: SAMARSKY DMITRY · SAMARSKY DMITRY A
29 granted patents·14 pending applications·787 citations·filing 1997–2024
98Inventor score
Files withPHIO PHARM CORP11SIRNAOMICS INC9RXI PHARMACEUTICALS CORP7KHVOROVA ANASTASIA6SILENCE THERAPEUTICS GMBH6
Top patents by PatentIndex Score
43 records- 0199US8796443B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2009·Granted Aug 5, 2014·105 cites·19 claims
- 0298US9938530B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted Apr 10, 2018·25 cites·19 claims
- 0398US9303259B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2013·Granted Apr 5, 2016·46 cites·12 claims
- 0498US9175289B2Reduced size self-delivering RNAi compoundsRXI PHARMACEUTICALS CORP·Filed 2014·Granted Nov 3, 2015·80 cites·17 claims
- 0598US9080171B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2011·Granted Jul 14, 2015·91 cites·15 claims
- 0698US8664189B2RNA interference in skin indicationsKHVOROVA ANASTASIA·Filed 2009·Granted Mar 4, 2014·60 cites·2 claims
- 0797US10913948B2RNA interference in dermal and fibrotic indicationsPHIO PHARM CORP·Filed 2018·Granted Feb 9, 2021·21 cites·7 claims
- 0897US10774330B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2015·Granted Sep 15, 2020·15 cites·19 claims
- 0997US10662430B2RNA interference in ocular indicationsPHIO PHARM CORP·Filed 2018·Granted May 26, 2020·14 cites·19 claims
- 1097US9340786B2RNA interference in dermal and fibrotic indicationsKHVOROVA ANASTASIA·Filed 2011·Granted May 17, 2016·49 cites·20 claims
- 1196US10240149B2Reduced size self-delivering RNAi compoundsPHIO PHARM CORP·Filed 2015·Granted Mar 26, 2019·23 cites·21 claims
- 1296US10184124B2RNA interference in ocular indicationsRXI PHARMACEUTICALS CORP·Filed 2015·Granted Jan 22, 2019·23 cites·14 claims
- 1396US10041073B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2011·Granted Aug 7, 2018·24 cites·24 claims
- 1496US9963702B2RNA interference in dermal and fibrotic indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted May 8, 2018·23 cites·20 claims
- 1595US11015198B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted May 25, 2021·14 cites·7 claims
- 1695US10138485B2Neutral nanotransportersKHVOROVA ANASTASIA·Filed 2009·Granted Nov 27, 2018·22 cites·15 claims
- 1795US9095504B2RNA interference in ocular indicationsLIBERTINE LYN·Filed 2011·Granted Aug 4, 2015·50 cites·10 claims
- 1894US11118178B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2019·Granted Sep 14, 2021·8 cites·10 claims
- 1994US10876119B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2018·Granted Dec 29, 2020·7 cites·20 claims
- 2094US10815485B2RNA interference in skin indicationsPHIO PHARM CORP·Filed 2018·Granted Oct 27, 2020·8 cites·5 claims
- 2194US8815818B2Phagocytic cell delivery of RNAISAMARSKY DMITRY·Filed 2009·Granted Aug 26, 2014·60 cites·17 claims
- 2293US11584933B2RNA interference in ocular indicationsPHIO PHARM CORP·Filed 2020·Granted Feb 21, 2023·2 cites·20 claims
- 2390US11396654B2Neutral nanotransportersPHIO PHARM CORP·Filed 2018·Granted Jul 26, 2022·4 cites·19 claims
- 2488US12084656B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2021·Granted Sep 10, 2024·1 cites·14 claims
- 2583US2025043288A1Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 2682US11414660B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Aug 16, 2022·2 cites·20 claims
- 2777US2021147849A1Reduced size self-delivering rnai compoundsPHIO PHARM CORP·Filed 2020·Application pending·0 cites
- 2874US2025313837A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 2973US2025313846A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 3072US2021261968A1Rna interference in dermal and fibrotic indicationsPHIO PHARM CORP·Filed 2021·Application pending·0 cites
- 3170US2025249027A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 3269US12378552B2Oligomeric compound for inhibiting expression of factor XISIRNAOMICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·20 claims
- 3368US11987794B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 3467US2023257753A1Products and compositionsSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 3561US2023089502A1Products and compositionsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3661US2023089915A1Products and compositionsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3758US2021332358A1MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOFSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 3856US2021371861A1Multi-Targeting Nucleic Acid Constructs Composed Of Multiple Oligonucleotides That Modulate Gene Expression Through Complimentary Interactions With TargetsSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 3955US2011251258A1Rnai constructs and uses thereofRXI PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 4053US2009131360A1Tripartite RNAi constructsRXI PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 4150US11299738B2Further novel oligonucleotide-ligand conjugatesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Apr 12, 2022·0 cites·23 claims
- 4250US5942395AHybrid ribozymes and methods of useUNIV MONTREAL·Filed 1997·Granted Aug 24, 1999·10 cites·26 claims
- 4334US2021253623A1Nucleic acid unit and polymeric nucleic acid and application thereofGUANGZHOU RIBOBIO CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dmitry Samarsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →